Who owns Pharmacyclics?

Key details on Pharmacyclics (Ticker: PCYC)

Who owns Pharmacyclics?

Is PCYC a good stock to own? Find out who bought Pharmacyclics, who sold Pharmacyclics (PCYC) stock, and who holds a large position in Pharmacyclics.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 9.66M $1.13B Sept. 30, 2014
T. Rowe Price Associates 7.75M $695.37M June 30, 2014
Ameriprise Financial 4.26M $381.91M June 30, 2014
Janus Capital Management 3.81M $447.16M Sept. 30, 2014
Vanguard 3.52M $413.26M Sept. 30, 2014
Capital World Investors^ 2.98M $267.06M June 30, 2014
PRIMECAP Management Company 2.31M $271.39M Sept. 30, 2014
OrbiMed Advisors 2.18M $32.29M Dec. 31, 2011
FMR 2.00M $235.40M Sept. 30, 2014
SUSQUEHANNA INTERNATIONAL 1.71M $201.11M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 1.53M $179.87M Sept. 30, 2014
FRED ALGER MANAGEMENT 1.46M $146.80M March 31, 2014
GOLDMAN SACHS 1.34M $134.27M March 31, 2014
STATE STREET CORPORATION 1.15M $135.26M Sept. 30, 2014
Franklin Resources 947900 $14.05M Dec. 31, 2011
S.A.C. Capital Advisors 939713 $99.40M Dec. 31, 2013
Bridger Management 900000 $13.34M Dec. 31, 2011
Barclays 895591 $94.04M Dec. 31, 2013
Columbus Circle Investors 883877 $88.58M March 31, 2014
Visium Asset Management 835788 $48.29M Dec. 31, 2012
Federated Investors 824125 $96.78M Sept. 30, 2014
QVT Financial 823163 $22.85M March 31, 2012

Who sold Pharmacyclics?

Fund Name Date Sold Number of Shares Sold Share Valuation
BVF Sept. 30, 2011 1.16M $13.70M
Balyasny Asset Management March 31, 2011 1.75M $10.28M
Sectoral Asset Management March 31, 2011 1.02M $5.98M
Perceptive Advisors Dec. 31, 2010 2.81M $17.07M
Renaissance Technologies Dec. 31, 2010 890330 $5.41M